Literature DB >> 22892660

[Frozen section diagnostics in visceral surgery. Liver, bile ducts and pancreas].

C Mogler1, C Flechtenmacher, P Schirmacher, F Bergmann.   

Abstract

Intraoperative examination of specimens from the liver, bile ducts, gallbladder and pancreas are widely used in routine fresh frozen section diagnostics. The main clinical requests focus on diagnosis of masses of unknown dignity as well as evaluation of surgical margins in oncological resections. In addition, assessment of organ quality for transplantation is also often required.

Mesh：

Year:  2012        PMID： 22892660     DOI： 10.1007/s00292-012-1602-z

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


  27 in total

Review 1.  An approach to the rational use of steatotic donor livers in liver transplantation.

Authors:  M A Urena; E Moreno Gonzalez; C J Romero; F C Ruiz-Delgado; C Moreno Sanz
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

Review 2.  Practical issues for frozen section diagnosis in gastrointestinal and liver diseases.

Authors:  Jayson R Miedema; Heike V Hunt
Journal:  J Gastrointestin Liver Dis       Date:  2010-06       Impact factor: 2.008

Review 3.  Frozen section examination of liver, gallbladder, and pancreas.

Authors:  Juan Lechago
Journal:  Arch Pathol Lab Med       Date:  2005-12       Impact factor: 5.534

Review 4.  When is steatosis too much for transplantation?

Authors:  Antonio Nocito; Ashraf Mohammad El-Badry; Pierre-Alain Clavien
Journal:  J Hepatol       Date:  2006-07-31       Impact factor: 25.083

5.  Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation.

Authors:  Anne Couvelard; Alain Sauvanet; Reza Kianmanesh; Pascal Hammel; Nathalie Colnot; Philippe Lévy; Philippe Ruszniewski; Pierre Bedossa; Jacques Belghiti
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

6.  The role of hepatic biopsy to detect macrovacuolar steatosis during liver procurement.

Authors:  G L Adani; U Baccarani; M Sainz-Barriga; D Lorenzin; V Bresadola; A Risaliti; C Avellini; G Trevisan; A De Candia; F Bresadola
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

7.  Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.

Authors:  Yuji Shingu; Tomoki Ebata; Hideki Nishio; Tsuyoshi Igami; Yoshie Shimoyama; Masato Nagino
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

8.  Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.

Authors:  Hanno Matthaei; Seung-Mo Hong; Skye C Mayo; Marco dal Molin; Kelly Olino; Raghunandan Venkat; Michael Goggins; Joseph M Herman; Barish H Edil; Christopher L Wolfgang; John L Cameron; Richard D Schulick; Anirban Maitra; Ralph H Hruban
Journal:  Ann Surg Oncol       Date:  2011-05-03       Impact factor: 5.344

9.  Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?

Authors:  Satoshi Nara; Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Nobuyoshi Hiraoka
Journal:  J Am Coll Surg       Date:  2009-09-19       Impact factor: 6.113

Review 10.  Frozen section diagnosis in tumors of the pancreas.

Authors:  L H Weiland
Journal:  Semin Diagn Pathol       Date:  1984-02       Impact factor: 3.464
View more
  2 in total

Review 1.  Donor liver histology--a valuable tool in graft selection.

Authors:  Christa Flechtenmacher; Peter Schirmacher; Peter Schemmer
Journal:  Langenbecks Arch Surg       Date:  2015-03-26       Impact factor: 3.445

Review 2.  [Donor liver histology : Joint recommendations of the DGP, DTG and DSO].

Authors:  C Schleicher; H-H Kreipe; P Schemmer; C P Strassburg; C-L Fischer-Fröhlich; A Rahmel; C Flechtenmacher
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.